The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lanza Robert since 2010.
The trader's CIK number is 1317093.
At the time of the last reporting, Lanza Robert was the Chief Scientific Officer of Advanced Cell Technology, Inc.. (stock ticker symbol OTCBB:ACTC).
Also see all insider trading activities at Advanced Cell Technology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | OCAT | 0 | $0 | 35,000 | $291,305 | 0 | $0 |
| 2014 | OCAT | 0 | $0 | 1,548,930 | $600,936 | 0 | $0 |
| 2012 | OCAT | 0 | $0 | 10,996,790 | $1,693,863 | 0 | $0 |
| 2011 | OCAT | 0 | $0 | 726,305 | $111,006 | 750,000 | $37,500 |
| 2010 | OCAT | 0 | $0 | 11,700,023 | $1,120,616 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-11-10 | OCAT | Sale | 35,000 | 8.32 | 291,305 |
| 2014-09-10 | ACTCD | Sale | 8,930 | 12.54 | 111,937 |
| 2014-09-08 | ACTCD | Sale | 15,000 | 10.04 | 150,525 |
| 2014-09-02 | ACTCD | Sale | 15,000 | 8.56 | 128,474 |
| 2014-09-03 | ACTCD | Sale | 10,000 | 9.00 | 90,000 |
| 2014-07-07 | ACTC | Sale | 745,000 | .08 | 59,600 |
| 2014-07-03 | ACTC | Sale | 755,000 | .08 | 60,400 |
| 2012-12-14 | ACTC | Sale | 1,338,490 | .06 | 78,970 |
| 2012-07-30 | ACTC | Sale | 1,500,000 | .08 | 121,500 |
| 2012-07-31 | ACTC | Sale | 500,000 | .08 | 40,000 |
| 2012-01-23 | ACTC | Sale | 1,000,000 | .17 | 175,000 |
| 2012-01-24 | ACTC | Sale | 6,658,300 | .19 | 1,278,393 |
| 2011-09-28 | ACTC | Sale | 118,080 | .15 | 17,948 |
| 2011-09-29 | ACTC | Sale | 608,225 | .15 | 93,058 |
| 2011-06-21 | ACTC | Option Ex | 750,000 | .05 | 37,500 |
| 2010-12-06 | ACTC | Sale | 1,271,864 | .14 | 171,701 |
| 2010-12-07 | ACTC | Sale | 728,136 | .15 | 107,035 |
| 2010-11-29 | ACTC | Sale | 1,000,000 | .08 | 83,000 |
| 2010-11-30 | ACTC | Sale | 3,800,000 | .10 | 383,800 |
| 2010-11-22 | ACTC | Sale | 782,000 | .07 | 57,868 |
| 2010-11-23 | ACTC | Sale | 679,000 | .08 | 51,604 |
| 2010-09-20 | ACTC | Sale | 600,000 | .07 | 40,800 |
| 2010-08-20 | ACTC | Sale | 600,000 | .07 | 45,000 |
| 2010-07-20 | ACTC | Sale | 497,150 | .07 | 35,297 |
| 2010-07-21 | ACTC | Sale | 102,850 | .07 | 7,199 |
| 2010-06-21 | ACTC | Sale | 600,000 | .10 | 58,200 |
| 2010-05-20 | ACTC | Sale | 600,000 | .07 | 39,600 |
| 2010-04-20 | OTCBB:ACTC | Sale | 439,023 | .09 | 39,512 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lanza Robert (Chief Scientific Officer of Advanced Cell Technology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.